Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03928041 · ClinicalTrials.gov registry record · NA
A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced Interbody Cages in the Lumbar Spine
A NA study of Degenerative Disc Disease Lumbar and Spondylolisthesis, Grade 1, sponsored by Invibio.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 2
- Study locations
NCT03928041 is a NA study of Degenerative Disc Disease Lumbar and Spondylolisthesis, Grade 1 that has completed, run by Invibio. The registered enrollment target is 22 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT03928041, a NA study of Degenerative Disc Disease Lumbar and Spondylolisthesis, Grade 1, has completed, sponsored by Invibio.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this trial is to collect clinical outcomes including radiographic and CT outcomes in patients who undergo interbody spinal fusion using the EVOS Lumbar Interbody System.
Conditions Studied
Interventions
- DEVICE Device: EVOS Lumbar Interbody System (EVOS-HA)
Study Locations (2)
North Carolina
- OrthoCarolina Research Institute - Charlotte
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2019-06-27 |
| Est. Completion | 2023-09-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03928041
The ClinicalTrials.gov registry entry for NCT03928041 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Invibio, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Degenerative Disc Disease Lumbar appearing as the primary indexed condition, and to 1 intervention - of which Device: EVOS Lumbar Interbody System (EVOS-HA) is the first listed.
NCT03928041 reports 2 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03928041 about?
NCT03928041 is a clinical study titled "A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced Interbody Cages in the Lumbar Spine". The purpose of this trial is to collect clinical outcomes including radiographic and CT outcomes in patients who undergo interbody spinal fusion using the EVOS Lumbar Interbody System.
What is the current status of trial NCT03928041?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2019-06-27. Estimated completion is 2023-09-25.
What conditions does trial NCT03928041 study?
This clinical trial studies the following conditions: Degenerative Disc Disease Lumbar, Spondylolisthesis, Grade 1.
What interventions are being tested in trial NCT03928041?
The interventions under investigation include: Device: EVOS Lumbar Interbody System (EVOS-HA) (DEVICE).
Who is sponsoring clinical trial NCT03928041?
This trial is sponsored by Invibio, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03928041 being conducted?
This trial has 2 study locations across North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Degenerative Disc Disease Lumbar
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Degenerative Disc Disease Lumbar
All registered trials for this condition
Spondylolisthesis, Grade 1
All registered trials for this condition
North Carolina
All trials with a study site in North Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.